Top Markets
Coin of the day
Evommune, Inc. Evommune, Inc.

Evommune, Inc.

EVMN
Classement en actions #13820
Evommune, Inc. is a United States-based clinical-stage biotechnology company... Evommune, Inc. is a United States-based clinical-stage biotechnology company dedicated to advancing novel therapeutic solutions. Their primary focus lies in addressing the underlying mechanisms of chronic inflammatory diseases. Initial clinical development efforts are concentrated on conditions such as chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. The company's investigational portfolio features EVO756, which is being developed for the treatment of chronic spontaneous urticaria (CSU) and atopic dermatitis (AD), and EVO301, intended for atopic dermatitis (AD) and ulcerative colitis (UC). Established in 2020, Evommune operates from its headquarters in Palo Alto, California.
Prix de l'action
$12.63
Capitalisation boursière
$458.19M
Changement (1 jour)
-3.26%
Changement (1 an)
-
Pays
US
Échange Evommune, Inc. (EVMN)

Catégorie

Historique du prix de l'action pour Evommune, Inc. (EVMN)
Prix de clôture le plus élevé : $13.94 le 2026-08-01

Prix de clôture le plus bas : $19.25 le 2025-11-01
Historique du prix de l'action de Evommune, Inc. de 2025 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 9.44%
2025 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$544.38 39.22%
US
$1.03K 45.21%
NL
$121.01 -13.08%
AU
$138.80 476.17%
US
$749.90 5.87%
CH